Maximum Standardized Uptake Value From Staging FDG-PET/CT Does not Predict Treatment Outcome for Early-Stage Non–Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy
- 15 November 2010
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 78 (4), 1033-1039
- https://doi.org/10.1016/j.ijrobp.2009.09.081
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Relationship Between Non-small Cell Lung Cancer FDG Uptake at PET, Tumor Histology, and Ki-67 Proliferation IndexJournal of Thoracic Oncology, 2008
- Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging ProjectJournal of Thoracic Oncology, 2008
- Stereotactic Body Radiation TherapyAmerican Journal of Clinical Oncology, 2007
- Factors involved in lymph node metastasis in clinical stage I non-small cell lung cancer—From studies of 604 surgical casesLung Cancer, 2007
- Stereotactic body radiation therapy for nonmetastatic lung cancer: An analysis of 75 patients treated over 5 yearsInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non–small-cell lung cancer: A modeling studyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinomaCancer, 2004
- Impact of FDG-PET on radiation therapy volume delineation in non–small-cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1992
- On the Origin of Cancer CellsScience, 1956